Advanced small cell carcinoma of the bladder successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy

101Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Undifferentiated small cell carcinoma of the bladder is a rare tumor with pathologic features similar to those of oat cell carcinoma of the lung. This neuroendocrine neoplasm of the bladder has a highly malignant biological behavior; most patients present with either locally advanced or distant metastatic disease and die despite aggressive therapy. Here the histologic, immunocytochemical, and ultrastructural features of small cell carcinoma of the bladder are reviewed in detail. In addition, two patients with advanced small cell carcinoma of the bladder who were treated successfully with radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy (M‐VAC) are presented. Both men had regional lymph node involvement and are disease free at follow‐up of 1 year and 2.5 years, respectively. This is the first report of combined surgical and M‐VAC chemotherapy in the treatment of undifferentiated small cell carcinoma of the bladder. Copyright © 1990 American Cancer Society

Cite

CITATION STYLE

APA

Oesterling, J. E., Brendler, C. B., Burgers, J. K., Marshall, F. F., & Epstein, J. I. (1990). Advanced small cell carcinoma of the bladder successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy. Cancer, 65(9), 1928–1936. https://doi.org/10.1002/1097-0142(19900501)65:9<1928::AID-CNCR2820650910>3.0.CO;2-X

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free